1. Home
  2. ORN vs ALDX Comparison

ORN vs ALDX Comparison

Compare ORN & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORN
  • ALDX
  • Stock Information
  • Founded
  • ORN 1994
  • ALDX 2004
  • Country
  • ORN United States
  • ALDX United States
  • Employees
  • ORN N/A
  • ALDX N/A
  • Industry
  • ORN Military/Government/Technical
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORN Industrials
  • ALDX Health Care
  • Exchange
  • ORN Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • ORN 339.4M
  • ALDX 342.3M
  • IPO Year
  • ORN 2007
  • ALDX 2014
  • Fundamental
  • Price
  • ORN $7.87
  • ALDX $4.90
  • Analyst Decision
  • ORN Strong Buy
  • ALDX Strong Buy
  • Analyst Count
  • ORN 2
  • ALDX 2
  • Target Price
  • ORN $11.25
  • ALDX $9.50
  • AVG Volume (30 Days)
  • ORN 445.4K
  • ALDX 781.4K
  • Earning Date
  • ORN 10-29-2025
  • ALDX 11-06-2025
  • Dividend Yield
  • ORN N/A
  • ALDX N/A
  • EPS Growth
  • ORN N/A
  • ALDX N/A
  • EPS
  • ORN 0.27
  • ALDX N/A
  • Revenue
  • ORN $837,494,000.00
  • ALDX N/A
  • Revenue This Year
  • ORN $4.83
  • ALDX N/A
  • Revenue Next Year
  • ORN $8.34
  • ALDX $63.48
  • P/E Ratio
  • ORN $28.95
  • ALDX N/A
  • Revenue Growth
  • ORN 15.85
  • ALDX N/A
  • 52 Week Low
  • ORN $4.64
  • ALDX $1.14
  • 52 Week High
  • ORN $9.95
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • ORN 57.53
  • ALDX 33.59
  • Support Level
  • ORN $7.48
  • ALDX $5.48
  • Resistance Level
  • ORN $7.71
  • ALDX $5.88
  • Average True Range (ATR)
  • ORN 0.34
  • ALDX 0.30
  • MACD
  • ORN 0.10
  • ALDX -0.13
  • Stochastic Oscillator
  • ORN 60.31
  • ALDX 1.54

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: